Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation
Author(s) -
Akihiko ISOBE,
Takashi Takeda,
Masahiro Sakata,
Akira Miyake,
T. Yamamoto,
Ryoko Minekawa,
Fumihito Nishimoto,
Y. Oskamoto,
Cheryl L. Walker,
Tadashi Kimura
Publication year - 2007
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/dem247
Subject(s) - uterine leiomyoma , angiotensin ii , leiomyoma , endocrinology , cell growth , medicine , telmisartan , angiotensin receptor , receptor , myometrium , angiotensin ii receptor type 1 , renin–angiotensin system , biology , uterus , pathology , blood pressure , biochemistry
Although uterine leiomyomas or fibroids are the most common gynecological benign tumor and greatly affect reproductive health and well-being, the pathophysiology and epidemiology of uterine leiomyomas are poorly understood. Elevated blood pressure has an independent, positive association with risk for clinically detected uterine leiomyoma. Angiotensin II (Ang II) is a key biological peptide in the renin-angiotensin system that regulates blood pressure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom